Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: - Coronavirus disease 2019 (COVID-19) was caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early December 2019. The illness starts out as a respiratory condition with a range of outcomes, including full recovery and long-term sequelae like respiratory difficulties, heart problems, stroke, and death. The goal of the current investigation was to evaluate the levels of inflammatory and non-inflammatory markers to check the severity and, consequently, gauge the prognosis of patients with COVID-19 infection.